Research ExplorerPublicationsTreatment of AIDS-related lymphomas: rituximab is beneficial...

Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.

Links

  • Christoph Wyen
  • Björn Jensen
  • Marcus Hentrich
  • Jan Siehl
  • Michael Sabranski
  • Stefan Esser
  • Daniel Gillor
  • Markus Müller
  • Jan van Lunzen
  • Timo Wolf
  • Johannes R Bogner
  • Jan C Wasmuth
  • Hildegard Christ
  • Gerd Fätkenheuer
  • Christian Hoffmann

Related Research units

Abstract

AIDS-related lymphomas (ARLs) significantly contribute to mortality in HIV-infected patients. Optimal chemotherapy treatment and the use of rituximab remain controversial. The aim of the present cohort study was to analyze the outcome of HIV-infected patients diagnosed with ARL, with regard to the use of rituximab, clinical characteristics and histopathological markers.

Bibliographical data

Original languageEnglish
Article number4
ISSN0269-9370
Publication statusPublished - 2012
pubmed 22112600